Darryl T. Martin

Yale University — United States

Medicine · Health Sciences

13h-index436citations51works3.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bladder and Urothelial Cancer Treatments(17), Prostate Cancer Diagnosis and Treatment(10), Cancer, Lipids, and Metabolism(10), Prostate Cancer Treatment and Research(7), Cancer, Hypoxia, and Metabolism(5)

Publications51 total

Evaluating the Therapeutic Role of Lymph Node Dissection in Variant Subtype Bladder Cancer
Cancers·2025Open Access
IP25-20 SOCIODEMOGRAPHIC DISPARITIES IN TISSUE-BASED GENOMIC TESTING FOR PROSTATE CANCER
The Journal of Urology·2025
EVALUATING CLINICAL OUTCOMES AND THE ROLE OF NEOADJUVANT CHEMOTHERAPY IN PLASMACYTOID UROTHELIAL CARCINOMA: INSIGHTS FROM A COMBINED NATIONAL AND INSTITUTIONAL SERIES
Urologic Oncology Seminars and Original Investigations·2025
Advancements in the Diagnosis, Treatment, and Risk Stratification of Non-Muscle Invasive Bladder Cancer
Current Oncology Reports·2025· 7 cited
Comparative Performance of Machine Learning Models in Reducing Unnecessary Targeted Prostate Biopsies
European Urology Oncology·2025· 4 citedOpen Access
Evaluating Treatment Patterns and the Role of Neoadjuvant Chemotherapy in Plasmacytoid Urothelial Carcinoma: Insights from a Combined National and Institutional Series
Cancers·2024· 2 citedOpen Access
Association Between the Decipher Genomic Classifier and Prostate Cancer Outcome in the Real-world Setting
European Urology Oncology·2024· 9 citedOpen Access
Development of a Longitudinal Prostate Cancer Transcriptomic and Clinical Data Linkage
JAMA Network Open·2024· 3 citedOpen Access
CRISPR-based genetic diagnostics in microgravity
Biosensors and Bioelectronics·2023· 4 citedOpen Access
Figure S2 from Glycoprotein-130 Expression Is Associated with Aggressive Bladder Cancer and Is a Potential Therapeutic Target
2023Open Access
Figure S3 from Glycoprotein-130 Expression Is Associated with Aggressive Bladder Cancer and Is a Potential Therapeutic Target
2023Open Access
Figure S2 from Glycoprotein-130 Expression Is Associated with Aggressive Bladder Cancer and Is a Potential Therapeutic Target
2023Open Access
Data from Glycoprotein-130 Expression Is Associated with Aggressive Bladder Cancer and Is a Potential Therapeutic Target
2023Open Access
Data from Glycoprotein-130 Expression Is Associated with Aggressive Bladder Cancer and Is a Potential Therapeutic Target
2023Open Access
Figure S1 from Glycoprotein-130 Expression Is Associated with Aggressive Bladder Cancer and Is a Potential Therapeutic Target
2023Open Access
Figure S3 from Glycoprotein-130 Expression Is Associated with Aggressive Bladder Cancer and Is a Potential Therapeutic Target
2023Open Access
Figure S1 from Glycoprotein-130 Expression Is Associated with Aggressive Bladder Cancer and Is a Potential Therapeutic Target
2023Open Access
MP17-02 ASSOCIATION BETWEEN THE DECIPHER GENOMIC CLASSIFIER AND PROSTATE CANCER OUTCOME IN A LARGE-SCALE REAL-WORLD DATASET
The Journal of Urology·2023
MP17-09 DEVELOPMENT OF A LONGITUDINAL PROSTATE CANCER TRANSCRIPTOMIC AND REAL-WORLD CLINICAL DATA LINKAGE
The Journal of Urology·2023· 1 cited
MP04-20 CHARACTERIZATION OF MITOCHONDRIAL DYSFUNCTION IN MODELS OF RENAL ONCOCYTOMA
The Journal of Urology·2023
page 1 of 3Next →

Frequent Co-authors

Robert M. Weiss(18), W. Mark Saltzman(14), Preston Sprenkle(12), Jill M. Steinbach-Rankins(11), Peter A. Humphrey(11), Hongliang Shen(9), Jamil Syed(9), Katelyn K. Johnson(8), Marcia A. Wheeler(7), Michael Leapman(7), Xi Zhu(7), Shogo Shimizu(6), Robert M. Weiss(5), Hristos Z. Kaimakliotis(4), Motoaki Saito(4), Angelique Levi(4), Elai Davicioni(4), Tyler M. Seibert(4), Daniel E. Spratt(4), Matthew R. Cooperberg(4)